Attitudes about genetic testing and genetic testing intentions in African American women at increased risk for hereditary breast cancer

Genetics in Medicine

Volumn 7, Issue 4, 2005, Pages 230-238

  Kessler, Lisa ^a   Collier, Aliya ^a   Brewster, Kiyona ^a   Smith, ChaChira ^b   Weathers, Benita ^a   Wileyto, E Paul ^a   Halbert, Chanita Hughes ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

African American; Attitudes; Genetic testing

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AFRICAN AMERICAN; ARTICLE; BREAST CANCER; CANCER RISK; FAMILIAL CANCER; FATALITY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MOTIVATION; ONCOGENE; PATIENT ATTITUDE; UNEMPLOYMENT;

AFRICAN AMERICANS; AGE FACTORS; BREAST NEOPLASMS; FEMALE; GENETIC SCREENING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTENTION; MULTIVARIATE ANALYSIS; PENNSYLVANIA; REGRESSION ANALYSIS; RISK ASSESSMENT; SOCIOECONOMIC FACTORS; WOMEN;

EID: 18344373876     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GIM.0000159901.98315.FE     Document Type: Article

References (37)

1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjorf JE, Hopper IL et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-1130.
2. Struewing IP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401-140S.
3. Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 1995;56:265-271.
4. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P et al, The Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998;62:676-689.
5. Panguluri RC, Brody LC, Modali R, Utley K, Campbell LA, Day AA et al. BRCA1 mutations in African Americans. Hum Genet 1999;105:28-31.
6. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002;20:1480-1490.
7. Gao Q, Tomlinson G, Das S, Cummings S, Sveen L, Fackenthal J et al. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer. Hum Genet 2000;107:186-191.
8. Peters N, Rose A, Armstrong K. The association between race and attitudes about predictive genetic testing. Cancer Epidemiol Biomarkers Prev 2004;13:361-365.
9. Donovan KA, Tucker DC. Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample. J Behav Med 2000;23:15-36.
10. Gwyn K, Vernon SW, Conoley PM. Intention to pursue genetic testing for breast cancer among women due for screening mammography. Cancer Epidemiol Biomarkers Prev 2003;12:96-102.
11. Hughes C, Caminero AG, Benkendorf J, Kerner J, Isaacs C, Barter J et al. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns 1997;32:51-62.
12. Lipkus IM, Iden D, Terrenoire J, Feaganes JR. Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African American women with and without a family history of breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:533-539.
13. Durfy SJ, Bowen DJ, McTiernan A, Sporleder J, Burke W. Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev 1999;8:369-375.
14. Kinney AY, Croyle RT, Dudley WN, Bailey CA, Pelias MK, Neuhausen SL. Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: A survey of a large African American kindred with a BRCA1 mutation. Prev Med 2001;33:543-551.
15. Myers RE, Hyslop T, Dozier KJ, Wolf TA, Burgh DY, Diehl JA et al. Intention to be tested for prostate cancer risk among African American men. Cancer Epidemiol Biomarkers Prev 2000;9:1323-1328.
16. Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL. Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 2003;21:593-601.
17. Parmigiani G, Berry D, Aguillar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and. BRCA2 Am J Genet 1998;62:145-158.
18. Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997;336:1409-1415.
19. Blackwood MA, Yang H, Margolin A. Predicted probability of breast cancer susceptibility gene mutations. Breast Cancer Res Treat 2001;69:223.
20. Powe BD. Cancer fatalism among elderly Caucasians and African Americans. Oncol Nurs Forum 1995;22:1355-1359.
21. Lerman C, Daly M, Sands C, Balshem A, Lustbader E, Heggan T et al. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 1993;85:1074-1080.
22. Lerman C, Kash K, Stefanek M. Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr 1994;16:171-176.
23. Hilton BA. The relationship of uncertainty, control, commitment, and threat of recurrence to coping strategies used by women diagnosed with breast cancer. J Behav Med 1989;12:39-54.
24. Taylor SE, Lichtman RR, Wood JV. Attributions, beliefs about control, and adjustment to breast cancer. J Pers Soc Psychol 1984;43:489-502.
25. Hughes C, Lerman C, Lustbader E. Ethnic differences in risk perception among women at increased risk for breast cancer. Breast Cancer Res Treat 1996;40:23-35.
26. Audrain J, Schwartz MD, Lerman C, Hughes C, Peshkin BN, Biesecker B. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal. Ann Behav Med 1997;19:370-377.
27. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994;12:843-850.
28. Lerman C, Biesecker B, Benkendorf IL, Kerner J, Gomez-Caminero A, Hughes C et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 1997;89:148-157.
29. Lerman C, Hughes C, Benkendorf JL, Biesecker B, Kerner J, Willison J et al. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev 1999;8:361-367.
30. Thompson HS, Valdimarsdottir HB, Duteau-Buck C, Guevarra J, Bovbjerg DH, Richmond-Avellaneda C et al. Psychosocial predictors of BRCA counseling and testing decisions among urban African American women. Cancer Epidemiol Biomarkers Prev 2002;11:579-585.
31. Hughes C, Fasaye GA, LaSalle VH, Finch C. Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Educ Couns 2003;51:107-114.
32. Powe BD, Finnie R. Cancer fatalism: the state of the science. Cancer Nurs 2003;26:454-465.
33. Hughes C, Peterson SK, Ramirez A, Gallion KJ, McDonald PG, Skinner CS et al. Minority recruitment in hereditary breast cancer research. Cancer Epidemiol Biomarkers Prev 2004;13:1146-1155.
34. Taylor KL, Siegel JE, Klimi KM, Lamdan RM, Shelby R, Hrywna M. Psychological adjustment among African American breast cancer patients: one-year follow-up results of a randomized psychoeducational group intervention. Health Psychol 2003;22:316-323,
35. Giwa KA, Ganz PA, Peterson L. Quality of life of African American and white long term breast carcinoma survivors. Cancer 1999;85:418-426.
36. Lerman C, Seay J, Bakshem A, Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 1995;57:385-392.
37. Lerman C, Narod S, Schulman K, Hughes C, Caminero AG, Boney G, Gold K et al. BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. JAMA 1996;275:1885-1892.